Tag: Phosphoinositide 3-kinase inhibitor

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Phosphoinositide 3-kinase inhibitor

UNITY-NHL Trial in R/R FL and MZL

Added to Collection on: 2021-05-27 14:26:15

Tags for this article:

Clinical medicine
Drugs
Medicine
Orphan drugs
Lymphoma
Non-Hodgkin lymphoma
Anatomical pathology
Phosphoinositide 3-kinase inhibitor
Umbralisib
Marginal zone B-cell lymphoma
Rituximab
Chemotherapy regimen
Jason M. Melear
Ian W. Flinn

Click the tags to see associated articles and topics

View Article Details
Kazia Therapeutics (ASX:KZA) enrols first patient in paxalisib study at Dana-Farber

Added to Collection on: 2021-06-07 03:00:00

Tags for this article:

Medical specialties
Oncology
Clinical medicine
Medicine
Brain tumor
HIV/AIDS
Drug discovery
Phosphoinositide 3-kinase inhibitor
Primary central nervous system lymphoma
Neuro-oncology
Glioblastoma
Phosphoinositide 3-kinase
Dana–Farber Cancer Institute
Lakshmi Nayak

Click the tags to see associated articles and topics

View Article Details
In Heavily Pretreated Relapsed/Refractory Follicular Lymphoma, Mosunetuzumab ...

Added to Collection on: 2021-12-12 01:12:50

Tags for this article:

Clinical medicine
Medicine
Cancer treatments
Lymphoma
Orphan drugs
Cancer immunotherapy
Chimeric antigen receptor T cell
Leukemia
Phosphoinositide 3-kinase inhibitor
Mantle cell lymphoma
Budde

Click the tags to see associated articles and topics

View Article Details
Loxo Oncology at Lilly Announces Updated Data from the Phase 1/2 BRUIN Clinical Trial for ...

Added to Collection on: 2021-12-12 21:05:06

Tags for this article:

Chemical compounds
Branches of biology
Organic compounds
Orphan drugs
Peripheral membrane proteins
Breakthrough therapy
Antineoplastic drugs
Bruton's tyrosine kinase
Chronic lymphocytic leukemia
Mantle cell lymphoma
Phosphoinositide 3-kinase inhibitor
Venetoclax
the university of texas md anderson cancer center

Click the tags to see associated articles and topics

View Article Details
TG Therapeutics Backpedals on BLA for Lymphoma, Leukemia Treatment | BioSpace

Added to Collection on: 2022-04-15 18:58:23

Tags for this article:

Health sciences
Orphan drugs
Clinical medicine
Medicine
Breakthrough therapy
Chronic lymphocytic leukemia
Umbralisib
Antineoplastic drugs
Food and Drug Administration
Accelerated approval
Ibrutinib
Phosphoinositide 3-kinase inhibitor
ublituximab
TG THERAPEUTICS

Click the tags to see associated articles and topics

View Article Details
FDA's tighter scrutiny on drug class leads TG Therapeutics to pull out of cancer - MedCity News

Added to Collection on: 2022-04-18 23:15:34

Tags for this article:

Medicine
Health sciences
Clinical medicine
Food and Drug Administration
Antineoplastic drugs
Orphan drugs
Breakthrough therapy
Drug discovery
Phosphoinositide 3-kinase inhibitor
Idelalisib
Accelerated approval
Duvelisib
TG THERAPEUTICS
TG
Michael Weiss

Click the tags to see associated articles and topics

View Article Details
TG Therapeutics: Ublituximab Could Achieve $1 Billion In Annual Sales By Year-End 2024

Added to Collection on: 2022-12-15 19:19:10

Tags for this article:

Health
Breakthrough therapy
Monoclonal antibodies
Genentech
Ocrelizumab
Drugs
Medicine
Phosphoinositide 3-kinase inhibitor
CD20
Food and Drug Administration
Umbralisib
ublituximab

Click the tags to see associated articles and topics

View Article Details
Roche's inavolisib combination reduces the risk of disease progression by 57% in ... - Yahoo Finance

Added to Collection on: 2023-12-08 22:22:09

Tags for this article:

Amides
Specialty drugs
Aminopyridines
Breakthrough therapy
Protein kinase inhibitors
Palbociclib
Phosphoinositide 3-kinase inhibitor
Alpelisib
Fulvestrant
Breast cancer
Triple-negative breast cancer
PI3K/AKT/mTOR pathway
F. Hoffmann-La Roche
San Antonio
Roche Group

Click the tags to see associated articles and topics

View Article Details
Inavolisib Plus Palbociclib and Fulvestrant Improves PFS in PIK3CA-Mutated HR+ Breast Cancer

Added to Collection on: 2023-12-08 18:14:54

Tags for this article:

Aminopyridines
Protein kinase inhibitors
Breakthrough therapy
Amides
Palbociclib
Fulvestrant
Genentech
Breast cancer
HER2
Inavolisib
Buparlisib
Phosphoinositide 3-kinase inhibitor

Click the tags to see associated articles and topics

View Article Details
2023-12-08 | OTCQX:RHHBY | Press Release | Roche Holdings ADR - Stockhouse

Added to Collection on: 2023-12-08 17:07:09

Tags for this article:

Breast cancer
Aminopyridines
Amides
Lactams
Palbociclib
Phosphoinositide 3-kinase inhibitor
Fulvestrant
Inavolisib
P110α
HER2
Genentech
Metastatic breast cancer

Click the tags to see associated articles and topics

View Article Details